Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).

Source:http://linkedlifedata.com/resource/pubmed/id/14662044

Download in:

View as

General Info

PMID
14662044